Z-0859-2016 Class II Terminated

Recalled by Medtronic Neuromodulation — Minneapolis, MN

FDA device recall Z-0859-2016 was initiated by Medtronic Neuromodulation on Jan 11, 2016 and is designated Class II. Reason for recall: Some Specify 5-6-5 and 2x8 surgical lead product labeling does not adequately distinguish between permanent surgical implant and trialing/screening use. The recall status is terminated (terminated Jan 20, 2017). Affected quantity: 51,138 (44,006 US; 9,132 OUS).

Recall Details

Product Type
Devices
Report Date
Mar 2, 2016
Initiation Date
Jan 11, 2016
Termination Date
Jan 20, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
51,138 (44,006 US; 9,132 OUS)

Product Description

Specify 5-6-5 Lead, Specify 2x8 Lead, Model Numbers: 39565, 39286. Spinal cord stimulation leads. Part of a neurostimulation system for treating chronic, intractable pain of the trunk and/or limbs-including unilateral or bilateral pain.

Reason for Recall

Some Specify 5-6-5 and 2x8 surgical lead product labeling does not adequately distinguish between permanent surgical implant and trialing/screening use.

Distribution Pattern

Worldwide Distribution, including US Nationwide.

Code Information

All lot/serial numbers are affected for both Model numbers: 39565 and 39286

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0859-2016
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.